Mar 6 |
Q4 2023 Sophia Genetics SA Earnings Call
|
Mar 5 |
SOPHiA GENETICS SA (SOPH) Q4 2023 Earnings Call Transcript
|
Mar 5 |
SOPHiA Genetics misses top-line and bottom-line estimates; initiates FY24 outlook
|
Mar 5 |
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
|
Mar 5 |
Earnings Scheduled For March 5, 2024
|
Feb 22 |
SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference
|
Feb 12 |
Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector
|
Feb 5 |
SOPHiA GENETICS SA's (NASDAQ:SOPH) top owners are retail investors with 46% stake, while 26% is held by institutions
|
Jan 25 |
SOPHiA GENETICS Supports Genetic Testing in Brazil
|
Jan 15 |
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India
|